Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Avecia Biotechnology

1995 FOUNDED
M&A STATUS
201-300 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of biotechnology-based medicines. The company develops DNA and RNA based therapeutics medicines for customers and is also engaged in providing nucleic acid manufacturing and development services..

Formerly Known As
Boston Biosystems
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Nitto Americas
Primary Office
  • 125 Fortune Boulevard
  • Milford, MA 01757
  • United States

+1 (508) 000-0000

Avecia Biotechnology Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Avecia Biotechnology‘s full profile, request access.

Request full access to PitchBook

Avecia Biotechnology Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Avecia Biotechnology‘s full profile, request access.

Request full access to PitchBook

Avecia Biotechnology Executive Team (3)

Name Title Board
Seat
Contact
Info
Don Short President & Chief Financial Officer
Mick McLean President

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »